|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, S231-S236, April 2009
Signal-activated phospholipase regulation of leukocyte chemotaxis
Departments of Cell Biology and Molecular Medicine, Lerner Research Institute and Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195 This work was supported by National Institutes of Health Grants HL-61971 and HL-74451 and by the National Center for Research Resources (CTSA 1UL1RR024989), Cleveland, OH. Published, JLR Papers in Press, Janury 2, 2009.
1 To whom correspondence should be addressed. e-mail: cathcam{at}ccf.org
Signal-activated phospholipases are a recent focus of the rapidly growing field of lipid signaling. The extent of their impact on the pathways regulating diverse cell functions is beginning to be appreciated. A critical step in inflammation is the attraction of leukocytes to injured or diseased tissue. Chemotaxis of leukocytes, a requisite process for monocyte and neutrophil extravasation from the blood into tissues, is a critical step for initiating and maintaining inflammation in both acute and chronic settings. Recent studies have identified new important and required roles for two signal-activated phospholipases A2 (PLA2) in regulating chemotaxis. The two intracellular phospholipases, cPLA2
Supplementary key words chronic inflammation macrophage lipid mediators monocyte Abbreviations: AA, arachidonic acid; Cox, cyclooxygenase; cPLA2, cytosolic phospholipase A2; Cyp, cytochrome p450 epoxygenase; EET, epoxyeicosatrienoic acids; iPLA2, calcium-independent phospholipase A2; LO, lipoxygenase; LPA, lysophosphatidic acid; MCP-1, monocyte chemoattractant protein-1; PA, phosphatidic acid; PLA2, phospholipase A2; PLC, phospholipase C; PLD, phospholipase D; PPAR
Related Webpages:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||